FDA 483 - Orfit Industries NV - May 17, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Orfit Industries NV, a medical device manufacturer in Wijnegem, Belgium, revealed significant deficiencies in their quality system. Observations included inadequate documentation of design review results for the RT-131, Mammo RX Breast Board, and insufficient frequency and documentation of management reviews. Additionally, the firm failed to perform quality audits covering all elements of the quality system, indicating a need for improved adherence to regulatory requirements.
ID · 0394cba2-3ac9-483f-ba0f-2e2f4ca3a250